Santa Clara, CA 5/3/12—Affymetrix has announced that it amended its existing agreement to acquire eBioscience, a provider of flow cytometry and immunoassay reagents for immunology and oncology research and diagnostics (see IBO 11/30/11), and expects to complete the transaction by June 30. Affymetrix will pay $315 million in cash for the company. “By amending the […]
Although daily world events and economic indicators can affect macroeconomic growth prospects, future sales growth for instrument and laboratory product sales generally are more determined by longer-term scientific and end-market trends. Nonetheless, macroeconomic conditions can have a delayed effect on instrument and lab product sales, as they ultimately affect investment decisions by end-user industries and […]
Pay Invoice
Latest Blogs
-
NIH Disruptions and Lab Tool Companies: Stocks React
April 30, 2025 1:17 pm
-
Federal R&D Obligations for the NIH Decline in FY24
March 27, 2025 3:02 pm
-
Paving The Way for Change: 10x Genomics Announces Corporate Strategies for a Fruitful 2025
February 26, 2025 1:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
